PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension-Reference-Cited by-同舟云学术

PCSK9-deficiency does not alter blood pressure and sodium balance in mouse models of hypertension

Published:2015-03 Issue:1 Volume:239 Page:252-259
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Berger Jean-Mathieu^ORCID,Vaillant Nathalie,Le May Cédric,Calderon Carolina,Brégeon Jeremy,Prieur Xavier,Hadchouel Juliette,Loirand Gervaise,Cariou Bertrand

Funder

Nouvelle Société Française d’Athérosclérose (NSFA)

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Seidah;Proc. Natl. Acad. Sci. U. S. A.,2003

2. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration;Zaid;Hepatology,2008

3. PCSK9 and LDL cholesterol: unravelling the target to design the bullet;Costet;Trends Biochem. Sci.,2008

4. PCSK9: a convertase that coordinates LDL catabolism;Horton;J. Lipid Res.,2009

5. Proprotein convertase subtilisin kexin type 9 null mice are protected from postprandial triglyceridemia;Le May;Arterioscler. Thromb. Vasc. Biol.,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations;Frontiers in Pharmacology;2024-07-30

2. The role of PCSK9 in heart failure and other cardiovascular diseases—mechanisms of action beyond its effect on LDL cholesterol;Heart Failure Reviews;2024-06-18

3. Dyslipidemia;Hypertension;2024

4. Pleiotropy of PCSK9: Functions in Extrahepatic Tissues;Current Cardiology Reports;2023-07-10

5. Insight into the Evolving Role of PCSK9;Metabolites;2022-03-17